Gain Therapeutics says motor function in Parkinson's stabilizes over 360 days with Rexaceract

Gain Therapeutics reports that motor function in Parkinson's disease patients stabilizes over 360 days with its drug candidate Rexaceract. The claim comes from a single social post and is unconfirmed.

Detected & updated continuously · Source: Nebula

Story subjects

Gain Therapeutics, Inc.Parkinson's disease

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula